Skip to content

Calaspargase pegol

Asparlas (calaspargase pegol) is an enzyme pharmaceutical. Calaspargase pegol was first approved as Asparlas on 2018-12-20. It is used to treat precursor cell lymphoblastic leukemia-lymphoma in the USA.
Trade Name Asparlas
Common Name Calaspargase pegol
Indication precursor cell lymphoblastic leukemia-lymphoma
Drug Class Enzymes; PEGylated compounds
Calaspargase pegol
Get full access now